- Brief Report
- Open access
- Published:
Spontaneous splenic infarction associated with sumatriptan use
The Journal of Headache and Pain volume 7, pages 214–216 (2006)
Abstract
Triptans are specific agonists of the serotonergic 5-HT1B/1D receptors that have increasingly been used in the treatment of migraine and cluster headaches. Though they are generally considered safe, there have been a few reports of myocardial infarction and stroke associated with triptan use. We report a patient who developed spontaneous splenic infarction after the use of sumatriptan for the treatment of migraine headache.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This is an open access article distributed under the terms of the Creative Commons Attribution Noncommercial License ( https://creativecommons.org/licenses/by-nc/2.0 ), which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
About this article
Cite this article
Arora, A., Arora, S. Spontaneous splenic infarction associated with sumatriptan use. J Headache Pain 7, 214–216 (2006). https://doi.org/10.1007/s10194-006-0291-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10194-006-0291-5